[Place of autologous and allogeneic hematopoietic stem cell transplantation in ovarian cancer].

Abstract:

:For several years, research for treatment of advanced ovarian cancer in first line or in relapse was made on the basis of two concepts. The first one is to improve the response rate by increasing the dose of chemotherapy delivered by high dose chemotherapy consolidation. The second concept is the development of an immunological antitumoral effect following allogeneic hematopoietic stem cells transplantation (HSC). The autologous HSC transplantation is required to first concept because of medullar toxicities induced by high dose chemotherapy. This therapeutic was widely studied in first line of advanced ovarian cancer. The recent phases III demonstrate an increase of the toxicity without efficacy improvement compared with the standard doses of chemotherapy. In relapse, the response rate is improved but an important toxicity is observed with low response duration. Evaluation of high dose of topotecan in association with the carboplatine is currently on going. Allogeneic HSC transplantation presents a potential interest because of immunogeneic control against tumour. However, the direct proof of immunotherapy efficacy on OC in a clinical study is still missing, toxicities should not be disregarded.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Nayl B,Cabrespine-Faugeras A,Maliki Y,Bay JO

doi

10.1684/bdc.2009.1004

subject

Has Abstract

pub_date

2009-12-01 00:00:00

pages

1225-32

issue

12

eissn

0007-4551

issn

1769-6917

pii

bdc.2009.1004

journal_volume

96

pub_type

杂志文章,评审
  • [Conservative management of malignant and borderline ovarian tumor].

    abstract::Conservative management of at least a part of one ovary and the uterus, in order to preserve fertility-potential, could be propose in most of patients with nonepithelial and borderline ovarian tumor. This conservative management could be performed even in patients with borderline ovarian tumor associated with noninvas...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Morice P,Camatte S,Wickart-Poque F,Rouzier R,Pautier P,Pomel C,Lhommé C,Haie-Meder C,Duvillard P,Castaigne D

    更新日期:2002-12-01 00:00:00

  • Remaining indications for total mastectomy in breast carcinoma

    abstract::Does radical mastectomy for cancer remain needed? Breast conserving treatment may be achieved by surgery, primary chemotherapy followed by radiotherapy and surgery. This article attempts at defining (according to clinical and pathological parameters of the tumor and patient's characteristics), when conservative treatm...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weber B,Demange L,Rigaud C,Fernandes-Valoni A

    更新日期:1998-09-01 00:00:00

  • [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].

    abstract::Between november 1993 and october 1996, a cervical screening program was proposed for women 25-65-year-old who tend to have little or no medical supervision, in three suburban districts of Lyon. The data and results of the two last Pap-smears have been collected together with details of gynecological follow-up. Both g...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mignotte H,Perol D,Fontanière B,Nachury LP,Blanc-Jouvand A,Fouillat V,Chauvin F,Lasset C

    更新日期:1999-06-01 00:00:00

  • [Treatment of locally extensive soft tissue sarcomas. Value of intra-arterial chemotherapy (author's transl)].

    abstract::Between 1964 and 1978, 21 patients with locally extensive soft tissue sarcoma received intal-arterial regional chemotherapy (IAC), combined with radiotherapy. Some patients were also submitted to conservative surgery. Although there were three serious accidents, one of which was lethal, the tolerance was considered ac...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Marée D,Bui NB,Chauvergne J,Avril A,Richaud P

    更新日期:1980-01-01 00:00:00

  • [Cell cycle and molecular targets: CDK inhibition].

    abstract::Protein phosphorylation is a fundamental post-translational modification. It regulates a large number of critical cellular processes (differentiation, division, proliferation, apoptosis). Cell division is a process including a series of phases by which a parent cell divides into two daughter cells. The cells enter the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1383

    authors: Carassou P,Meijer L,Le Moulec S,Aoun J,Bengrine-Lefèvre L

    更新日期:2012-02-01 00:00:00

  • [Infiltrating carcinoma of the uterine cervix: epidemiology, prognostic factors, therapeutic strategies].

    abstract::In industrialized countries cervical cancer has decreased over the past decades. This, thanks to wide spread screening campaigns of precancerous lesions and microinvasive diseases through regular pap smears starting from the beginning of sexual activity. The diagnostic is realized earlier, thus increasing the rate of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pereira R,Renard A,Boulbair F,Touboul E,Lefranc JP

    更新日期:1998-11-01 00:00:00

  • [Linac-based stereotactic radiosurgery and radiotherapy].

    abstract::Stereotactic radiation therapy, consisting in irradiating the tumor with a high dose per fraction, has a therapeutic potential because of excellent local control. This technique requires a high accuracy level in order to minimize the risk of normal tissue toxicity. Initially used for cerebral localization, the stereot...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1144

    authors: Ayadi M,Ginestet C,Gassa F,Claude L,Mazeron JJ

    更新日期:2010-07-01 00:00:00

  • [Modification of the cellular cytoskeleton and hepatic tumor promotion].

    abstract::Non transformed epithelial hepatic cells (established cell line and adult rat hepatocytes) treated by liver tumor promoters, phenobarbital and biliverdin, for 24 and 48 h showed a fragmentation and loss of F-actin and a depolymerisation of microtubules. This pattern closely resembles that of transformed cells which we...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Decloître F,Martin M,Ouldelhkim M,Nizard C

    更新日期:1990-01-01 00:00:00

  • [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].

    abstract::The serious digestive side effects of the selective inhibitors the inducible cyclooxygenase-2 are reduced by 60% as compared to the nonselective non-steroidal anti-inflammatory drugs. The main risk factors associated with gastro-intestinal ulcers caused by the latter were found also with the selective inhibitors taken...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lamarque D

    更新日期:2004-05-01 00:00:00

  • [Radioimmunotargeting: diagnosis and therapeutic use].

    abstract::Monoclonal antibodies labeled with a radionuclide make feasible the in vivo radioimmunotargeting of tumor cells. This targeting could be performed for diagnosis, using gamma emitters, or for therapeutic purpose when antibodies are labeled with beta- and in the future alpha-emitters. Diagnosis applications (tumor detec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vuillez JP

    更新日期:2000-11-01 00:00:00

  • [Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the c...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2016.09.005

    authors: Dubois V,Brignier A,Elsermans V,Gagne K,Kennel A,Pedron B,Picard C,Ravinet A,Varlet P,Cesbron A,Delbos F,Yakoub-Agha I,Loiseau P

    更新日期:2016-11-01 00:00:00

  • [Oncolor is ten years old: the age of discretion for the Lorraine network in oncology].

    abstract::Oncolor, network in oncology in Lorraine, was born ten years ago, from a group of professionals in the field of oncology who worked closed together with regional administrative authorities. Oncolor was created with respect of equilibrium between the different regional partners avoiding struggle for power. Oncolor was ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bey P,Bouvier R,David M,Delena G,Garin H,Kessler Y,Klein I,Krakowski I,Lang MP,Leclercq JM,Level MC,Luron R,May I,Nabet M,Ruck S,Sommelet D,Theobald S,Unvois R,Walter S

    更新日期:2004-07-01 00:00:00

  • [Carcinoma of the nasopharynx (cavum) : clinical and developmental aspects].

    abstract::Between 1959 and 1974, two hundred and ninety six carcinomas of the nasopharynx were seen at the Institut Gustave-Roussy, in adults. 78% were in man. The most frequently encountered were undifferentiated or poorly differentiated forms, 76% of cases. 38% only of the patients had their birthplace in France. On the first...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Brugère J,Eschwege F,Schwaab G,Micheau C,Cachin Y

    更新日期:1975-07-01 00:00:00

  • [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

    abstract::Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it's possible to hope prolonged survival. This treatment is more and more codified. Four indications are recognized by some tree national evaluation committees: ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0553

    authors: Eveno C,Dagois S,Guillot E,Gornet JM,Pocard M

    更新日期:2008-01-01 00:00:00

  • [Management of febrile neutropenias in adolescents and young adults: Differences of practice between adult and pediatric units].

    abstract:INTRODUCTION:Adolescents and young adults (AYA, 15-25years old) with cancer are treated either in adult or pediatric units. Management of febrile neutropenia (FN) is different between these units. Monitoring rules and indications of hospitalization are often stricter in pediatrics. This study evaluates if these differe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.08.001

    authors: Penel-Page M,Normand C,Bertrand A,Levard A,Boyle H,Riberon C,Marec-Berard P

    更新日期:2015-11-01 00:00:00

  • [Combination of etoposide, cisplatin and ifosfamide (VPH) in the salvage chemotherapy of relapsing or refractory aggressive malignant lymphoma. Study of 51 patients].

    abstract::Fifty-one patients with non-Hodgkin's lymphoma refractory or relapsing after CHOP-like regimen, underwent a salvage chemotherapy by VPH: etoposide 100 mg/m2/d, D1 to D3, cisplatin 20 mg/m2/d, D1 to D5, ifosfamide 1 g/m2/d D1 to D5, mesna 1.2 g/m2/d D1 to D5, every 4 weeks. Among 46 evaluable patients for efficacy, 21 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Eghbali H,Catry-Thomas I,Soubeyran P,Bonnel C,Hoerni B

    更新日期:1994-09-01 00:00:00

  • [Breast cancer management before 40 years: what change in one decade? A retrospective study at the "Institut de cancérologie de Lorraine": 2002-2012].

    abstract:INTRODUCTION:Breast cancer of young women has medico-psychological issues, particularly in the perspective of "after cancer" period. The objective of the study was to analyze the changes in management, in a decade including the publication of Cancer Plans I and II. METHODS:This retrospective unicentric study involved ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30049-7

    authors: Soussoko M,Salleron J,Desandes E,Lesur A

    更新日期:2019-12-01 00:00:00

  • [Respiratory sequellae after alternated chemotherapy and radiotherapy for small cell anaplastic cancer].

    abstract::The authors analyze the respiratory sequelae in 19 patients with limited small cell lung carcinoma who survived for more than 30 months following an alternating chemo-radiotherapeutic combined regimen. The clinical tolerance measured with respiratory functional test is acceptable. In two patients an effort dyspnea is ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: de Cremoux H,Baldeyrou P,Martin M,Ruffié P,Arriagada R,Le Chevalier T

    更新日期:1987-01-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [Adaptation and validation of a brief screening questionnaire of depressive disorders in patients with cancer: Q2i study].

    abstract:BACKGROUND:Depression is a sustainable state of deep sadness and abatement. It is frequently identified in patients with cancer and often undervalued by oncologists. The reduced PRIME-MD questionnaire is a questionnaire of 2 items validated in French. However, it has been neither translated nor validated in French. The...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.09.008

    authors: Barriere J,Mari V,Cherikh F,Largillier R,Ettaiche M,Schiappa R,Chamorey E,Ferrero JM,Gal J

    更新日期:2016-02-01 00:00:00

  • [Molecular (de)regulation and cancer: new therapeutic strategies].

    abstract::The considerable progress of molecular biology within the past twenty years has permitted a more and more detailed characterization of the molecular mechanisms regulating cell proliferation. The corollary to these discoveries has been the identification of different deregulations yielding to cell transformation and ca...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Boulukos KE,Carlotti F,Pognonec P

    更新日期:2001-04-01 00:00:00

  • [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].

    abstract::Seventy children (3.7 +/- 3.3 y) with definitely confirmed diagnosis of neuroblastoma had 115 whole body scans carried out 24 h after injection of 3.7 MBq/kg of I-123 mIBG (83 scans) or 0.7 MBq/kg of I-131 mIBG (17 scans) or 0.9 to 4.5 GBq of I-131 mIBG (15 post-therapeutic scans). The scans were interpreted as positi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lumbroso J,Guermazi F,Hartmann O,Coornaert S,Rabarison Y,Lemerle J,Parmentier C

    更新日期:1988-01-01 00:00:00

  • [Advances in adults' gliomas biology, imaging and treatment].

    abstract::A better understanding of gliomas biology is now leading to a combined histo-molecular classification of these tumors. In anaplastic gliomas ongoing studies depend on 1p/19q codeletion status and in glioblastomas on MGMT methylation status. Advanced brain tumor imaging elicits a better identification of gliomas evolut...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.1019

    authors: Ducray F,Dutertre G,Ricard D,Gontier E,Idbaih A,Massard C

    更新日期:2010-01-01 00:00:00

  • [Pharmacologic bases of chemotherapy of brain tumors in children].

    abstract::In terms of pharmacology, drug delivery is an important obstacle in the development of brain tumor chemotherapy. The blood-brain barrier limits the drug penetration in normal brain tissue around the tumor and at distant potential metastatic sites. In the tumor, the altered blood-brain barrier, ie blood-tumor barrier, ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vassal G

    更新日期:1990-01-01 00:00:00

  • [Access to fertility preservation for adolescents and young adults aged 15 to 24 years with cancers in Auvergne, France].

    abstract:INTRODUCTION:Cancers of adolescents and young adults have particular epidemiological specificities. The improvement in their survival should be accompanied by an increased consideration of the treatments' side effects, among which the potential decrease in fertility. The objective of the study was to describe the acces...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.03.013

    authors: Grèze V,Mechdoud S,Vorilhon S,Isfan F,Rouel N,Chaput L,Brugnon F,Kanold J

    更新日期:2020-01-01 00:00:00

  • An ethics dilemma: when parents and doctors disagree on the best treatment for the child.

    abstract::The increasing complexity of present day medicine--with highly effective and yet risky treatments, individual and collective expectations, and evolving ideological and cultural landmarks--often gives rise to difficult ethical problems. Specific meetings are valuable for understanding such problems, acquiring the relev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Oppenheim D,Brugières L,Corradini N,Vivant F,Hartmann O

    更新日期:2004-09-01 00:00:00

  • [Cancer of the prostate: estrogen therapy].

    abstract::From 1941, estrogens are usually used in the treatment of prostatic carcinoma, wrongly in case of adjuvant hormonotherapy and exceedingly because of cardiovascular toxicity from over dosages. A recall of their mechanism of action and toxicity allows to argue about the palliative treatment and to look to their use for ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mauriac L,Richaud P,Mage P,Thomas L,Lamarche P

    更新日期:1986-01-01 00:00:00

  • [Docetaxel and gastric cancer].

    abstract::There are very few active drugs in the treatment of metastatic gastric carcinoma. Among new drugs, docetaxel has shown one of the most important activity. With precise evaluation of objective response, this drug has demonstrated a 20% response rate in monotherapy. The favorable toxicity profile of this compound allowe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ducreux M,Boige V,Roth A

    更新日期:2004-03-01 00:00:00

  • [Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].

    abstract::This paper recalls the definition of the Gleason index and describes the five architectural types that enable a calculation of the index. The conditions of the practical application of the index are defined, with a discussion of reproducibility of results based on current literature and the author's experience. The in...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Saint-André JP,Rousselet MC,Six P,Bertrand G,Soret JY

    更新日期:1985-01-01 00:00:00

  • [Cyclooxygenase 2 inhibitors and cancer chemoprevention].

    abstract::Chemoprevention is the use of natural or synthetic compounds in order to reverse, suppress or prevent the carcinogenic process. Among the many pathways dysregulated during the carcinogenic process, cyclooxygenase-2 (Cox2) seems to be one of the most promising pathways to target in order to achieve chemopreventive and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Masmoudi A,Chevalier TL,Sabatier L,Soria JC

    更新日期:2004-05-01 00:00:00